Can Hims & Hers Stock Fall 30%?
Hims & Hers Health (HIMS) shares fell 42.8% over the past year, and historical data suggests a further 30% drop is possible. The stock underperformed the S&P 500 in past market shocks, with an average decline of 37.0%. The company reported negative operating cash flow in Q2 2026, despite sales growth of 38.2%, and expects lower adjusted EBITDA for the fiscal year.
How this was made
The 30-second read
Why it matters
No new data; the recap reinforces a bearish outlook.
Market read
The piece provides a historical performance review without fresh information, offering limited trading relevance.
What to watch
Potential strategic partnership or acquisition rumors not covered in the article.
Background
The article reviews Hims & Hers Health's performance over the past year, noting a 42.8% share decline, cash‑flow issues, margin compression, and a possible 30% further drop.
Ticker impact
The article recaps Hims & Hers Health's recent cash burn, margin decline and a 30% potential drop, without new disclosures.
likely further pressure as investors digest deteriorating cash flow and margin trends
The piece only repeats already‑public quarterly results and guidance, indicating no new positive trigger.
Market effects
Highlights weakness in the telehealth/consumer health sector amid cash‑flow strain.
U.S. market focus; no broader regional effect.
Limited to investors tracking Hims & Hers.
Counterpoint
If the weight‑loss segment scales, the cash burn could be temporary and the stock may be oversold.
Key entities
- CompanyHims & Hers Health
U.S. telehealth and consumer health company (ticker HIMS).
